Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aceclofenac is a nonsteroidal anti-inflammatory drug (NSAID) and an analog of diclofenac. It is primarily used to relieve pain and inflammation associated with chronic musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Aceclofenac works by inhibiting the enzyme cyclooxygenase (COX), which is responsible for the synthesis of prostaglandins—mediators involved in pain, swelling, inflammation, and fever. Compared to other NSAIDs like naproxen or indomethacin, aceclofenac has a lower incidence of gastrointestinal side effects[1][3][5][7][10]. It is typically administered orally as film-coated tablets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aceclofenac.